Lowe invited to address major cannabis conference
Renowned Jamaican scientist and entrepreneur Dr Henry Lowe has been invited to be the special guest presenter at the Eighth National Clinical Conference on Cannabis Therapeutics next month.
The conference, being held under the theme 'The Endocannabinoid System and Age-Related Illnesses', is scheduled for May 8-10 in Portland, Oregon, USA.
Its main purpose is to educate healthcare professionals, scientists and the public about the use of cannabis (ganja) for the treatment of a variety of health-related problems. In addition to examining the potential of cannabis as a treatment for many diseases, the policy, regulatory and institutional framework to create an enabling environment for the development of medical cannabis will also be assessed.
According to a news release from Lowe's Environmental Health Foundation (EHF) Group, several distinguished scientists and healthcare professionals will be participating and making presentations at the conference, which is being sponsored by the University of California's San Francisco School of Medicine.
One of the major aspects of Dr Lowe's presentation will be the potential use of cannabis in cancer therapy and to alleviate the symptoms associated with mid-life crises such as anxiety and depression, the EHF said.
"Being the only presenter from this region, Dr Lowe's invitation to speak at this conference at this time is significant and underscores the extent of the recognition of his work in the applied sciences with special relevance to healthcare issues, and more particularly his knowledge and contributions to advance medical cannabis internationally," the news release added.
Dr Lowe has done significant research and development work on medical cannabis and is recognised as one of the pioneers of researching, developing and commercialising medical cannabis since the 1970s, the release added.
He has developed strategic working relationships with scientists at the University of the West Indies, Mona as well as other academic and research and development institutions.
Having recognised the social, health and economic demand and potential of medical cannabis, Dr Lowe launched Medicanja Limited in December 2013, the first medical cannabis company aimed at undertaking cutting-edge research and development on the medicinal potential of cannabis as well as a variety of medicinal and healthcare products which now represent a multi-billion dollar market in the USA and Europe.
The launch of Medicanja created worldwide media attention, being reported in the Caribbean, North America, Europe, Asia and Australia as a major innovation with great promise for Jamaica and the world.
Lowe recently co-authored Ganja - the Jamaican and Global Connection, a comprehensive handbook for anyone interested in the medicinal aspects of cannabis.
The EHF Group said that Dr Lowe will share highlights from the conference with local scientists, doctors and policymakers in an
effort to support research and development and commercialisation of medical cannabis in Jamaica.